Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124199513 | 12419951 | 3 | F | 20160419 | 20160920 | 20160531 | 20160927 | EXP | FR-PFIZER INC-2016277516 | PFIZER | 63.00 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124199513 | 12419951 | 1 | PS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous drip | 120 MG, DAILY | Y | 11856 | 120 | MG | |||||||
| 124199513 | 12419951 | 2 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous drip | 80 MG, DAILY | Y | 11856 | 80 | MG | |||||||
| 124199513 | 12419951 | 3 | SS | LOXEN /00639802/ | NICARDIPINE | 1 | Intravenous (not otherwise specified) | STRENGTH 5 MG/5 ML | Y | 0 | SOLUTION FOR INFUSION | ||||||||
| 124199513 | 12419951 | 4 | SS | LOXEN L P | NICARDIPINE HYDROCHLORIDE | 1 | Oral | 50 MG, 2X/DAY | 600 | MG | Y | 0 | 50 | MG | CAPSULE | BID | |||
| 124199513 | 12419951 | 5 | SS | SANDIMMUNE | CYCLOSPORINE | 1 | Intravenous drip | 15 MG, 2X/DAY | 1350 | MG | Y | 0 | 15 | MG | SOLUTION FOR INFUSION | BID | |||
| 124199513 | 12419951 | 6 | SS | SANDIMMUNE | CYCLOSPORINE | 1 | Intravenous drip | 20 MG, DAILY | 1350 | MG | Y | 0 | 20 | MG | SOLUTION FOR INFUSION | ||||
| 124199513 | 12419951 | 7 | SS | CYMEVAN | GANCICLOVIR | 1 | Intravenous drip | 260 MG, 2X/DAY | 10400 | MG | Y | 0 | 260 | MG | BID | ||||
| 124199513 | 12419951 | 8 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 1 G, 2X/DAY | 90 | G | Y | 0 | 1 | G | BID | ||||
| 124199513 | 12419951 | 9 | C | FUNGIZONE | AMPHOTERICIN B | 1 | Oral | 250 MG, UNK | 0 | 250 | MG | CAPSULE | |||||||
| 124199513 | 12419951 | 10 | C | CLAMOXYL /00249601/ | AMOXICILLIN | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | CAPSULE | |||||||
| 124199513 | 12419951 | 11 | C | VFEND | VORICONAZOLE | 1 | Oral | 0 | FILM-COATED TABLET | ||||||||||
| 124199513 | 12419951 | 12 | C | WELLVONE | ATOVAQUONE | 1 | Oral | 750 MG/5 ML | 0 | ORAL SUSPENSION | |||||||||
| 124199513 | 12419951 | 13 | C | GAVISCON /01405501/ | SODIUM ALGINATESODIUM BICARBONATE | 1 | Oral | 0 | |||||||||||
| 124199513 | 12419951 | 14 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | 50 UG, UNK | 0 | 50 | UG | ||||||||
| 124199513 | 12419951 | 15 | C | SMECTA /07327601/ | 2 | Oral | 3 G, UNK | 0 | 3 | G | |||||||||
| 124199513 | 12419951 | 16 | C | TIORFAN | RACECADOTRIL | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | CAPSULE | |||||||
| 124199513 | 12419951 | 17 | C | CHOLURSO | URSODIOL | 1 | Oral | 250 MG, UNK | 0 | 250 | MG | FILM-COATED TABLET | |||||||
| 124199513 | 12419951 | 18 | C | REFRESH | UNSPECIFIED INGREDIENT | 1 | Ophthalmic | EYE DROPS IN SINGLE-USE VIAL | 0 | ||||||||||
| 124199513 | 12419951 | 19 | C | VITABACT | PICLOXYDINE DIHYDROCHLORIDE | 1 | Ophthalmic | 0.173 MG/0.4 ML, EYE DROPS IN SINGLE-DOSE VIAL | 0 | ||||||||||
| 124199513 | 12419951 | 20 | C | ELUDRIL /02860401/ | CHLORHEXIDINE GLUCONATECHLOROBUTANOL | 1 | Buccal | 0 | |||||||||||
| 124199513 | 12419951 | 21 | C | MIKICORT | BUDESONIDE | 1 | Oral | STRENGTH 3 MG, ENTERIC-COATED CAPSULE | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124199513 | 12419951 | 1 | Acute graft versus host disease |
| 124199513 | 12419951 | 3 | Hypertension |
| 124199513 | 12419951 | 4 | Hypertension |
| 124199513 | 12419951 | 5 | Prophylaxis against transplant rejection |
| 124199513 | 12419951 | 7 | Cytomegalovirus infection |
| 124199513 | 12419951 | 8 | Prophylaxis against transplant rejection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124199513 | 12419951 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124199513 | 12419951 | Fall | |
| 124199513 | 12419951 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124199513 | 12419951 | 1 | 20160326 | 20160413 | 0 | |
| 124199513 | 12419951 | 2 | 20160413 | 0 | ||
| 124199513 | 12419951 | 3 | 20160308 | 20160414 | 0 | |
| 124199513 | 12419951 | 4 | 20160414 | 20160428 | 0 | |
| 124199513 | 12419951 | 5 | 20160306 | 20160420 | 0 | |
| 124199513 | 12419951 | 6 | 20160421 | 20160425 | 0 | |
| 124199513 | 12419951 | 7 | 20160331 | 20160427 | 0 | |
| 124199513 | 12419951 | 8 | 20160306 | 20160510 | 0 |